Changing it Up

Drug discovery is harder than it used to be, says Technology Review's Susan Young. Pharma pipelines are freezing up and fewer drugs are getting past early-stage testing. Further, there are entrepreneurs who have new ideas, but no money to bring them to completion, Young says. So pharma, biotech, and academia are trying to solve their collective problems by coming together with venture capitalists to create new drug discovery funding models, she adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.